Cargando…

Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer

BACKGROUND: There is no standard therapy for second-line treatment of gemcitabine-refractory pancreatic cancer patients with poor performance status. A combination of chemotherapy drugs 5-fluorouracil (5-FU), leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) or 5-fluorouracil/leucovorin plus nano...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Se Jun, Kim, Hyunho, Shin, Kabsoo, Lee, Myung Ah, Hong, Tae Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Retrospective Cohort Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883178/ https://www.ncbi.nlm.nih.gov/pubmed/31798782 http://dx.doi.org/10.4251/wjgo.v11.i11.1021

Ejemplares similares

Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2021)

Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma
por: Park, Se Jun, et al.
Publicado: (2023)

First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy
por: Han, Sung Yong, et al.
Publicado: (2020)

FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
por: Cho, In Rae, et al.
Publicado: (2020)

Efficacy of multiple biliary stenting for refractory benign biliary strictures due to chronic calcifying pancreatitis
por: Ohyama, Hiroshi, et al.
Publicado: (2017)

Comparison of efficacy between adjuvant chemotherapy and chemoradiation therapy for pancreatic cancer: AJCC stage-based approach
por: You, Min Su, et al.
Publicado: (2020)

Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching
por: Adhoute, Xavier, et al.
Publicado: (2022)

Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
por: Park, Se Jun, et al.
Publicado: (2021)

Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma
por: Zheng, Wen-Heng, et al.
Publicado: (2019)

Elemene-containing hyperthermic intraperitoneal chemotherapy combined with chemotherapy for elderly patients with peritoneal metastatic advanced gastric cancer
por: Chen, Zhi-Xiong, et al.
Publicado: (2022)

Clinical benefit and tolerability of adjuvant intraperitoneal chemotherapy in patients who have or have not received neoadjuvant chemotherapy for advanced ovarian cancer
por: Meghal, Trishala, et al.
Publicado: (2019)

Simultaneous occurrence of autoimmune pancreatitis and pancreatic cancer in patients resected for focal pancreatic mass
por: Macinga, Peter, et al.
Publicado: (2017)

Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
por: Liu, Zi-Ning, et al.
Publicado: (2021)

Resection of pancreatic cystic neoplasms in recurrent acute pancreatitis prevents recurrent pancreatitis but does not identify more malignancies
por: Muniraj, Thiruvengadam, et al.
Publicado: (2021)

Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis
por: Jain, Animesh, et al.
Publicado: (2017)

Pancreatic necrosis and severity are independent risk factors for pancreatic endocrine insufficiency after acute pancreatitis: A long-term follow-up study
por: Yu, Bing-Jun, et al.
Publicado: (2020)

Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States
por: Lew, Daniel, et al.
Publicado: (2022)

Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study
por: Sheng, Xue-Qing, et al.
Publicado: (2022)

Comparison of clinicopathological characteristics between resected ampullary carcinoma and carcinoma of the second portion of the duodenum
por: Nishio, Kohei, et al.
Publicado: (2022)

Zinc deficiency in patients with chronic pancreatitis
por: Vujasinovic, Miroslav, et al.
Publicado: (2019)

Complications and management of forgotten long-term biliary stents
por: Sohn, Se Hoon, et al.
Publicado: (2017)

Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors
por: Chen, Hong-Yu, et al.
Publicado: (2020)

Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12
por: Werner, Christoph R, et al.
Publicado: (2016)

Predictive factors of histological response of colorectal liver metastases after neoadjuvant chemotherapy
por: Serayssol, Chloé, et al.
Publicado: (2019)

Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer
por: Spiegelberg, Julia, et al.
Publicado: (2020)

Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients
por: Liu, Ken, et al.
Publicado: (2017)

Hospital contacts with alcohol problems prior to liver cirrhosis or pancreatitis diagnosis
por: Askgaard, Gro, et al.
Publicado: (2017)

Portosplenomesenteric vein thrombosis in patients with early-stage severe acute pancreatitis
por: Ding, Ling, et al.
Publicado: (2018)

Computed tomography perfusion imaging evaluation of angiogenesis in patients with pancreatic adenocarcinoma
por: Liu, Wen, et al.
Publicado: (2022)

Intraoperative intraperitoneal chemotherapy increases the incidence of anastomotic leakage after anterior resection of rectal tumors
por: Wang, Zhi-Jie, et al.
Publicado: (2019)

Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study
por: Cashin, Peter H, et al.
Publicado: (2020)

Extrapancreatic necrosis volume: A new tool in acute pancreatitis severity assessment?
por: Cucuteanu, Bogdan, et al.
Publicado: (2021)

Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer
por: Balaban, Daniel Vasile, et al.
Publicado: (2022)

Periportal thickening on magnetic resonance imaging for hepatic fibrosis in infantile cholestasis
por: Lee, Myung Hwan, et al.
Publicado: (2020)

Assessment of the July effect in post-endoscopic retrograde cholangiopancreatography pancreatitis: Nationwide Inpatient Sample
por: Schulman, Allison R, et al.
Publicado: (2017)

Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer
por: Sperti, Cosimo, et al.
Publicado: (2017)

Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy
por: Polk, Stuart L, et al.
Publicado: (2020)

Clinical value of extended lymphadenectomy in radical surgery for pancreatic head carcinoma at different T stages
por: Lyu, Shao-Cheng, et al.
Publicado: (2022)

Risk factors and prediction score for chronic pancreatitis: A nationwide population-based cohort study
por: Lin, Yen-Chih, et al.
Publicado: (2018)

Age, socioeconomic features, and clinical factors predict receipt of endoscopic retrograde cholangiopancreatography in pancreatic cancer
por: Rustgi, Sheila D, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rgkrvt53rp7nf979a664j38nua